Myeloperoxidase as possible diagnostic and prognostic marker of acute coronary syndrome;Il ruolo della mieloperossidasi come marker diagnostico e prognostico nella cardiopatia ischemica

Recenti Progressi in Medicina

Volumn 102, Issue 11, 2011, Pages 447-450

  Gustapane, Massimo ^a   Cardillo, Maria Teresa ^a   Biasillo, Gina ^a   Biasucci, Luigi Marzio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Acute coronary syndrome; Ischemic heart disease; Myeloperoxidase; Myocardial infarction

Indexed keywords

MYELOPEROXIDASE;

ACUTE CORONARY SYNDROME; ANALYTIC METHOD; DISEASE MARKER; HUMAN; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; HUMANS; PEROXIDASE; PROGNOSIS; RISK ASSESSMENT;

EID: 84055193905     PISSN: 00341193     EISSN: 20381840     Source Type: Journal    
DOI: 10.1701/975.10611     Document Type: Review

References (19)

1. Naruko T, Ueda M, Haze K, et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002; 106: 2894-900. (Pubitemid 35424738)
2. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 2001; 158: 879-91. (Pubitemid 32221781)
3. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985; 14: 157-67. (Pubitemid 15241170)
4. Holvoet P. Oxidative modification of low-density lipoproteins in atherothrombosis. Acta Cardiol 1998; 53: 253-60. (Pubitemid 29070682)
5. Shao B, Oda MN, Oram JF, Heinecke JW. Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein. Curr Opin Cardiol 2006; 21: 322-8. (Pubitemid 44315065)
6. Zhou T, Zhou SH, Qi SS, Shen XQ, Zeng GF, Zhou HN. The effect of atorvastatin on serum myeloperoxidase and CRP levels in patients with acute coronary syndrome. Clin Chim Acta 2006; 368: 168-72. (Pubitemid 43776034)
7. Zhang R, Brennan ML, Fu X, et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001; 286: 2136-42. (Pubitemid 34041599)
8. Meuwese MC, Stroes ESG, Hazen SL, et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals. The EPIC-Norfolk prospective population study. J Am Coll Cardiol 2007; 50: 159-65. (Pubitemid 47002189)
9. Biasucci LM, D'Onofrio G, Liuzzo G, et al. Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. J Am Coll Cardiol 1996; 27: 611-6. (Pubitemid 26080385)
10. Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 2002; 347: 5-12. (Pubitemid 34728951)
11. Ferrante G, Nakano M, Prati F, et al. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study. Circulation 2010; 122: 2505-13.
12. Baldus S, Heeschen C, Meinertz T, et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003; 108: 1440-5. (Pubitemid 37176448)
13. Brennan ML, Penn MS, Van Lente F, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003; 349: 1595-604. (Pubitemid 37288567)
14. Apple FS, Smith SW, Pearce LA, Schulz KM, Ler R, Murakami MM. Myeloperoxidase improves risk stratification in patients with ischemia and normal cardiac troponin I concentrations. Clin Chem 2011; 57: 603-8.
15. Scirica BM, Sabatine MS, Jarolim P, et al. Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial. Eur Heart J 2011; 32: 697-705.
16. Blankenberg S, Zeller T, Saarela O, et al. MORGAM Project. Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project. Circulation 2010; 121: 2388-97.
17. Rudolph V, Goldmann BU, Bös C, et al. Diagnostic value of MPO plasma levels in patients admitted for suspected myocardial infarction. Int J Cardiol 2010 Sep 14 [Epub ahead of print].
18. Sawicki M, Sypniewska G, Kozinski M, et al. Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes. Eur J Clin Invest 2011; 41: 667-71.
19. Eggers KM, Dellborg M, Johnston N, et al. Myeloperoxidase is not useful for the early assessment of patients with chest pain. Clin Biochem 2010; 43: 240-5.